𝔖 Bobbio Scriptorium
✦   LIBER   ✦

DIFFERENTIAL RESPONSIVENESS OF PROSTATIC ACID PHOSPHATASE AND PROSTATE-SPECIFIC ANTIGEN mRNA TO ANDROGEN IN PROSTATE CANCER CELLS

✍ Scribed by Ming-Fong Lin; Ming-Shyue Lee; Renee Garcia-Arenas; Fen-Fen Lin

Publisher
Elsevier Science
Year
2000
Tongue
English
Weight
296 KB
Volume
24
Category
Article
ISSN
1065-6995

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Androgens regulate the expression of both human prostatic acid phosphatase (PAcP) and prostate‐specific antigen (PSA), two major prostate epithelium‐specific differentiation antigens. Due to the important role of these two enzymes as prostate epithelium differentiation markers, we investigated their regulation of expression at the mRNA level in LNCaP human prostate carcinoma cells. Interestingly, phenol red, a pH indicator in the culture medium, promoted cell growth. To eliminate this non‐specific effect, a phenol red‐free, steroid‐reduced medium was utilized. When high‐density cells were grown in that medium, 5α‐dihydrotestosterone (DHT) suppressed PAcP but stimulated PSA. However, tumor promoter phorbol ester 12‐ o ‐tetradecanoyl phorbol‐13‐acetate (TPA) functioned as a potent inhibitor of both PAcP and PSA expression. Prolonged treatment with DHT as well as TPA resulted in a similar down‐regulation of protein kinase C and cellular PAcP activities. Thus, the levels of PAcP and PSA mRNA are differentially regulated by androgens in LNCaP cells.

📜 SIMILAR VOLUMES

Prostatic carcinoma metastatic to bone:
Prostatic carcinoma metastatic to bone: Sensitivity and specificity of prostate-specific antigen and prostatic acid phosphatase in decalcified material
✍ Niranjan T. Shah; Steven E. Tuttle; Stephan L. Storbel; Leena Gandhi 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 346 KB

Decalcified bone marrow biopsies containing metastatic tumor from 36 patients were stained for prostate-specific antigen (PSA) and prostatic acid phosphatase (PAP) using the avidin biotin compIex (ABC) immunoperoxidase technique. Of these patients, 22 had known prostate primaries, ten had known nonp

Immunoreactivity for prostate-specific a
Immunoreactivity for prostate-specific antigen and prostatic acid phosphatase in adenocarcinoma of the prostate: Relation to progression following radical prostatectomy
✍ Sauvageot, Jurgita; Epstein, Jonathan I. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 33 KB 👁 2 views

## Background: Although, in general, immunoperoxidase staining for prostate-specific antigen (psa) and prostate-specific acid phosphatase (psap) cannot distinguish between benign and malignant prostatic epithelium, immunoreactivity of these antigens may be helpful in predicting prognosis of prostat

Quantitative expression profile of andro
Quantitative expression profile of androgen-regulated genes in prostate cancer cells and identification of prostate-specific genes
✍ Linda L. Xu; Yong Ping Su; Ron Labiche; Takehiko Segawa; Naga Shanmugam; David G 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 247 KB 👁 1 views

Quantitative expression profile of androgen-regulated genes (ARGs) was evaluated in the hormone-responsive prostate cancer cell line LNCaP by serial analysis of gene expression (SAGE). A total of 83,489 SAGE tags representing 23,448 known genes or expressed sequence tags (ESTs) and 1,655 potentially

Characterization of residual tumor cells
Characterization of residual tumor cells following radical radiation therapy for prostatic adenocarcinoma; Immunohistochemical expression of prostate-specific antigen, prostatic acid phosphatase, and cytokeratin 8
✍ Ljung, Gunilla; Norberg, Mona; Holmberg, Lars; Busch, Christer; Nilsson, Sten 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 301 KB 👁 2 views

## Background: Our knowledge about the nature and biological activity of tumor cells residing in the prostate gland after radical radiotherapy (rrt) is limited. ## Methods: In the present study, residual tumor in core biopsies taken from 37 patients after an average of 6.8 years follow-up after r

The chromatin remodeling factor SRCAP mo
The chromatin remodeling factor SRCAP modulates expression of prostate specific antigen and cellular proliferation in prostate cancer cells
✍ Artur Slupianek; Smitha Yerrum; Fayez F. Safadi; M. Alexandra Monroy 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 227 KB 👁 1 views

## Abstract The SNF2‐related CBP activator protein (SRCAP) serves as a coactivator for several nuclear receptors including the androgen receptor (AR). SRCAP is an ATPase that is the core subunit of a large multiprotein complex and was shown to incorporate the histone variant H2A.Z into nucleosomes.

Induction of prostate tumor-specific CD8
Induction of prostate tumor-specific CD8+ cytotoxic T-lymphocytes in vitro using antigen-presenting cells pulsed with prostatic acid phosphatase peptide
✍ Peshwa, Madhusudan V.; Shi, Jia Dong; Ruegg, Curtis; Laus, Reiner; van Schooten, 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB 👁 2 views

## BACKGROUND. Most strategies in cancer immunotherapy are aimed at the induction of a strong cellular immune response against the tumor. Particularly, CD8 + T lymphocytes have been proven in multiple animal models to be critical for the eradication of solid tumors. METHODS. We used a population o